➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
McKinsey
McKesson
Express Scripts
Johnson and Johnson

Last Updated: February 25, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for cetirizine hydrochloride; pseudoephedrine hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00334698 Study to Assess the Effect of a Combination of Cetirizine With Pseudoephedrine Versus Cetirizine Alone on Symptoms in Patients With Allergic Rhinitis Completed GlaxoSmithKline N/A 2006-07-01 The aim of this study is to assess the efficacy on nasal congestion and other allergic symptoms and the onset of action of an oral combination of cetirizine and pseudoephedrine in comparison to the single substances under controlled pollen exposure in an Environmental Challenge Chamber (ECC).
NCT00334698 Study to Assess the Effect of a Combination of Cetirizine With Pseudoephedrine Versus Cetirizine Alone on Symptoms in Patients With Allergic Rhinitis Completed Fraunhofer-Institute of Toxicology and Experimental Medicine N/A 2006-07-01 The aim of this study is to assess the efficacy on nasal congestion and other allergic symptoms and the onset of action of an oral combination of cetirizine and pseudoephedrine in comparison to the single substances under controlled pollen exposure in an Environmental Challenge Chamber (ECC).
NCT00474890 Study to Compare the Effect of a Combination of Cetirizine With Pseudoephedrine Versus Placebo on Symptoms in Patients With Allergic Rhinitis Within/Out of Season Completed Fraunhofer-Institute of Toxicology and Experimental Medicine N/A 2007-06-01 A previous study has shown very clearly that the treatment with the combination of cetirizine and pseudoephedrine is superior to the treatment with the single agents regarding the reduction of symptoms in patients with allergic rhinitis. These data, obtained after controlled pollen exposure out of the pollen season, showed highly reproducible individual responses prior to dosing. It is not clear, however, whether the same results can be obtained during the pollen season, when additional natural pollen exposure may influence the variability of the individual reactions.
NCT00881127 To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fasting Conditions Completed Sandoz Phase 1 2005-07-01 To demonstrate the relative bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg ER tablets under fasting conditions.
NCT00881634 To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fed Conditions Completed Sandoz Phase 1 2005-06-01 To demonstrate the relative bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg ER tablets under fed conditions.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for cetirizine hydrochloride; pseudoephedrine hydrochloride

Condition Name

Condition Name for cetirizine hydrochloride; pseudoephedrine hydrochloride
Intervention Trials
Allergies 2
Seasonal Allergic Rhinitis 1
Rhinitis 1
Atopy 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for cetirizine hydrochloride; pseudoephedrine hydrochloride
Intervention Trials
Rhinitis, Allergic 2
Rhinitis 2
Rhinitis, Allergic, Seasonal 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for cetirizine hydrochloride; pseudoephedrine hydrochloride

Trials by Country

Trials by Country for cetirizine hydrochloride; pseudoephedrine hydrochloride
Location Trials
Germany 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for cetirizine hydrochloride; pseudoephedrine hydrochloride

Clinical Trial Phase

Clinical Trial Phase for cetirizine hydrochloride; pseudoephedrine hydrochloride
Clinical Trial Phase Trials
Phase 1 2
N/A 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for cetirizine hydrochloride; pseudoephedrine hydrochloride
Clinical Trial Phase Trials
Completed 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for cetirizine hydrochloride; pseudoephedrine hydrochloride

Sponsor Name

Sponsor Name for cetirizine hydrochloride; pseudoephedrine hydrochloride
Sponsor Trials
Fraunhofer-Institute of Toxicology and Experimental Medicine 2
Sandoz 2
GlaxoSmithKline 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for cetirizine hydrochloride; pseudoephedrine hydrochloride
Sponsor Trials
Industry 3
Other 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
Boehringer Ingelheim
Express Scripts
Medtronic
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.